Usage of Meropenem/Gentamicin Versus Ceftazidime/Avibactam in ARDS

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

July 5, 2018

Primary Completion Date

December 28, 2019

Study Completion Date

December 30, 2019

Conditions
Ventilator Associated Pneumonia
Interventions
DRUG

meropenem

meropenem one gram slowly IV infusion every 8 hours for 14 days

DRUG

ceftazidime 2 grams and avibactam 500

received ceftazidime 2 grams and avibactam 500 mg every 8 hours for 14 days in solution for injection(sodium chloride 9 mg/mL (0.9%), sodium chloride 4.5 mg/mL, dextrose 25 mg/mL, 0.45% sodium chloride, 2.5% dextrose and/or Lactated Ringer's solution).

DEVICE

ventilator

all patients selected to be ventilated for 14 days

Trial Locations (1)

21944

King abd el Aziz specialist hospital, Ta'if

All Listed Sponsors
lead

King Abdul Aziz Specialist Hospital

NETWORK

NCT04402359 - Usage of Meropenem/Gentamicin Versus Ceftazidime/Avibactam in ARDS | Biotech Hunter | Biotech Hunter